TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)
Titel:
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)
Auteur:
Colombo, Ilaria Koster, Kira-Lee Holer, Lisa Haefliger, Simon Rabaglio, Manuela Bastian, Sara Schwitter, Michael Eckhardt, Katrin Hayoz, Stefanie Mc Laughlin, Anna M. Kloft, Charlotte Klose, Marian Halbherr, Stefan Baumgartner, Christian Sessa, Cristiana Stathis, Anastasios Hess, Dagmar Joerger, Markus